Yüklüyor......
Efficacy of ESHAP Regimen in Transplant Ineligible Patients With Relapsed/Refractory T-Cell Lymphoma
BACKGROUND: Salvage chemotherapy is the mainstay for the treatment of relapsed/refractory peripheral T-cell lymphomas (R/R PTCLs). ESHAP regimen, consisting of etoposide, methylprednisolone, high-dose Ara-C, and cisplatin is considered one of the well-accepted regimens for R/R lymphoma. Though, the...
Kaydedildi:
| Yayımlandı: | J Hematol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elmer Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7155849/ https://ncbi.nlm.nih.gov/pubmed/32300428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jh459w |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|